An Animal Explant Model for the Study of Human Cutaneous Squamous Cell Carcinoma

被引:2
|
作者
Belkin, Daniel A. [1 ]
Chen, Jie [2 ]
Mo, Jonathan L. [2 ]
Rosoff, James S. [2 ]
Goldenberg, Sagit [2 ]
Poppas, Dix P. [2 ]
Krueger, James G. [3 ]
Herschman, Miriam [4 ]
Mitsui, Hiroshi [3 ]
Felsen, Diane [2 ]
Carucci, John A. [4 ]
机构
[1] Weill Cornell Med Coll, Dept Dermatol, New York, NY USA
[2] Weill Cornell Med Coll, Dept Urol, Inst Pediat Urol, New York, NY USA
[3] Rockefeller Univ, Invest Dermatol Lab, New York, NY 10021 USA
[4] NYU, Langone Med Ctr, Ronald O Perelman Dept Dermatol, New York, NY 10003 USA
来源
PLOS ONE | 2013年 / 8卷 / 10期
关键词
NF-KAPPA-B; TUMOR MICROENVIRONMENT; XENOGRAFT MODEL; NUDE RATS; CANCER; TRANSFORMATION; METASTASIS; APOPTOSIS; MIGRATION; INVASION;
D O I
10.1371/journal.pone.0076156
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
We established a human tissue explant model to facilitate study of cutaneous squamous cell carcinoma. We accomplished this by implanting debulked SCC, from surgical discard, into nude rats. Human SCC remained viable and continued to proliferate for at least 4 weeks and showed evidence of neovascularization. At 4 weeks, SCC implants showed a trend toward increased PCNA positive cells compared to fresh SCC cells/mm(2) tissue) supporting continued proliferation throughout engraftment. Von Willebrand's Factor (VWF) positive cells were found within implants and likely represented rat vessel neovascularization. Human Langerhans' (Langerin+) cells, but no T cells (CD3+, CD8+, FoxP3+), macrophages (CD163), or NK cells (NKp46), were present in SCC implants at 4 weeks. These findings support the possibility that LCs fail to migrate from cutaneous SCC and thus contribute to lack of effective antitumor response. Our findings also provide a novel model system for further study of primary cutaneous SCC.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Advances in cutaneous squamous cell carcinoma
    Winge, Marten C. G.
    Kellman, Laura N.
    Guo, Konnie
    Tang, Jean Y.
    Swetter, Susan M.
    Aasi, Sumaira Z.
    Sarin, Kavita Y.
    Chang, Anne Lynn S.
    Khavari, Paul A.
    NATURE REVIEWS CANCER, 2023, 23 (07) : 430 - 449
  • [32] Advances in cutaneous squamous cell carcinoma
    Mårten C. G. Winge
    Laura N. Kellman
    Konnie Guo
    Jean Y. Tang
    Susan M. Swetter
    Sumaira Z. Aasi
    Kavita Y. Sarin
    Anne Lynn S. Chang
    Paul A. Khavari
    Nature Reviews Cancer, 2023, 23 : 430 - 449
  • [33] Retinoids in Cutaneous Squamous Cell Carcinoma
    Everts, Helen B.
    Akuailou, Eleonore-Nausica
    NUTRIENTS, 2021, 13 (01) : 1 - 18
  • [34] Facial cutaneous squamous cell carcinoma
    Aslam, Arif M.
    Patel, Anand N.
    BMJ-BRITISH MEDICAL JOURNAL, 2016, 352
  • [35] Pitfall cutaneous Squamous Cell Carcinoma
    Haiduk, J.
    Poenitzsch, I
    Monecke, A.
    Dumann, K.
    Ziemer, M.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 : 40 - 41
  • [36] Histopathology of cutaneous squamous cell carcinoma
    Maguire, B
    Smith, NP
    CLINICS IN DERMATOLOGY, 1995, 13 (06) : 559 - 568
  • [37] Cutaneous papillary squamous cell carcinoma
    Noriki Fujimoto
    Kazuya Teramura
    Gen Nakanishi
    Toshihiro Tanaka
    European Journal of Dermatology, 2014, 24 : 379 - 380
  • [38] The Cutaneous Squamous Cell Carcinoma - An Update
    Burda, Birgit
    Schultz, Erwin S.
    LARYNGO-RHINO-OTOLOGIE, 2023, 102 (10) : 735 - 741
  • [39] Cutaneous squamous-cell carcinoma
    Pollock, J
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (04): : 296 - 296
  • [40] Cutaneous papillary squamous cell carcinoma
    Fujimoto, Noriki
    Teramura, Kazuya
    Nakanishi, Gen
    Tanaka, Toshihiro
    EUROPEAN JOURNAL OF DERMATOLOGY, 2014, 24 (03) : 379 - 380